• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析对血管内容量和血管活性激素的影响。

Influence of hemodialysis on intravascular volume and vasoactive hormones.

作者信息

Katzarski K S, Randmaa I, Bergström J

机构信息

Department of Clinical Science, Huddinge University Hospital, Karolinska Institutet, Stockholm, Sweden.

出版信息

Clin Nephrol. 1999 Nov;52(5):304-11.

PMID:10584994
Abstract

BACKGROUND

The posthemodialysis plasma level of atrial natriuretic peptide (ANP) has been proposed as an index for an adequate fluid state in hemodialysis (HD) patients.

PATIENTS AND METHODS

We investigated the effect of fluid removal during HD on the interaction between intravascular volume and the vasoactive hormones ANP, vasopressin, adrenaline, noradrenaline, renin and aldosterone in 16 HD patients. Intravascular volume was examined with the 131I-labeled albumin method for blood volume (BV) and ultrasound for measurement of inferior vena cava diameter (IVCD).

RESULTS

There was a significant decrease in BV, IVCD and ANP, but not in the other vasoactive hormones. Based on BV and IVCD measurements, the predialysis plasma ANP levels in the normovolemic and hypovolemic patients were significantly higher than in the hypervolemic patients. There was no significant difference between the postdialysis ANP levels in the hypervolemic and normovolemic patients and no significant correlations between ANP and BV and IVCD, respectively, but postdialysis ANP correlated significantly with the ultrafiltration rate (r = -0.51, p < 0.05), noradrenaline (r = 0.54, p < 0.05) and change in vasopressin (r = -0.50, p < 0.05). There were also correlations between ANP and age before HD (r = 0.50, p < 0.05) and after HD (r = 0.70, p < 0.0025).

CONCLUSION

We conclude that the usefulness of the plasma ANP level for assessment of the fluid state in HD patients is limited, since age and other factors than those directly related to volume influence the concentration of ANP.

摘要

背景

血液透析后心房利钠肽(ANP)的血浆水平已被提议作为血液透析(HD)患者体液状态是否合适的一个指标。

患者与方法

我们研究了16例HD患者在血液透析过程中液体清除对血管内容量与血管活性激素ANP、血管加压素、肾上腺素、去甲肾上腺素、肾素和醛固酮之间相互作用的影响。采用131I标记白蛋白法检测血容量(BV)以评估血管内容量,并用超声测量下腔静脉直径(IVCD)。

结果

BV、IVCD和ANP显著降低,但其他血管活性激素未降低。根据BV和IVCD测量结果,血容量正常和血容量不足患者透析前血浆ANP水平显著高于血容量过多患者。血容量过多和血容量正常患者透析后ANP水平无显著差异,且ANP与BV和IVCD之间分别无显著相关性,但透析后ANP与超滤率显著相关(r = -0.51,p < 0.05)、与去甲肾上腺素显著相关(r = 0.54,p < 0.05)以及与血管加压素变化显著相关(r = -0.50,p < 0.05)。ANP与HD前年龄(r = 0.50,p < 0.05)和HD后年龄(r = 0.70,p < 0.0025)也存在相关性。

结论

我们得出结论,血浆ANP水平用于评估HD患者体液状态的作用有限,因为年龄以及其他与容量无直接关系的因素会影响ANP的浓度。

相似文献

1
Influence of hemodialysis on intravascular volume and vasoactive hormones.血液透析对血管内容量和血管活性激素的影响。
Clin Nephrol. 1999 Nov;52(5):304-11.
2
Response of vasoactive substances to intermittent ultrafiltration in normotensive hemodialysis patients.血压正常的血液透析患者血管活性物质对间歇性超滤的反应
Nephron. 1993;65(2):266-72. doi: 10.1159/000187486.
3
Response of vasoactive substances to reduction of blood volume during hemodialysis in hypotensive patients.低血压患者血液透析期间血管活性物质对血容量减少的反应。
Clin Nephrol. 1993 Apr;39(4):198-204.
4
Vasoactive hormones during hemodialysis with intermittent ultrafiltration.
ASAIO Trans. 1990 Jul-Sep;36(3):M367-9.
5
Evaluation of markers to estimate volume status in hemodialysis patients: atrial natriuretic peptide, inferior vena cava diameter, blood volume changes and filtration coefficients of microvasculature.评估用于估计血液透析患者容量状态的标志物:心房利钠肽、下腔静脉直径、血容量变化和微血管滤过系数。
Ther Apher Dial. 2007 Apr;11(2):131-7. doi: 10.1111/j.1744-9987.2007.00471.x.
6
[Response of vasoactive substance to blood pressure changes during hemodialysis in uremic patients].[尿毒症患者血液透析期间血管活性物质对血压变化的反应]
Pol Arch Med Wewn. 1999 Sep;102(3):763-71.
7
Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.采用N端前心钠素、心钠素及超声检查评估慢性肾衰竭患者的液体平衡。
Acta Physiol Scand. 2001 Feb;171(2):117-22. doi: 10.1046/j.1365-201x.2001.00792.x.
8
Hormonal responses to synthetic atrial natriuretic peptide in patients on regular hemodialysis.
Acta Endocrinol (Copenh). 1988 Oct;119(2):257-62. doi: 10.1530/acta.0.1190257.
9
Neurohumoral responses to a single haemodialysis in chronic renal patients.
Acta Physiol Scand. 1999 Jan;165(1):25-31. doi: 10.1046/j.1365-201x.1999.00443.x.
10
A critical evaluation of ultrasound measurement of inferior vena cava diameter in assessing dry weight in normotensive and hypertensive hemodialysis patients.超声测量下腔静脉直径评估血压正常和高血压血液透析患者干体重的批判性评价
Am J Kidney Dis. 1997 Oct;30(4):459-65. doi: 10.1016/s0272-6386(97)90302-4.

引用本文的文献

1
Echocardiographic assessment of cardiac structure and function in chronic renal disease.慢性肾病心脏结构和功能的超声心动图评估
J Echocardiogr. 2019 Sep;17(3):115-122. doi: 10.1007/s12574-019-00436-x. Epub 2019 Jul 8.
2
Comparison of multiple fluid status assessment methods in patients on chronic hemodialysis.慢性血液透析患者多种液体状态评估方法的比较
Int Urol Nephrol. 2017 Mar;49(3):525-532. doi: 10.1007/s11255-016-1473-y. Epub 2016 Dec 10.
3
The maintenance and monitoring of perioperative blood volume.围手术期血容量的维持和监测。
Perioper Med (Lond). 2013 May 7;2(1):9. doi: 10.1186/2047-0525-2-9.
4
Comparison and Reproducibility of Techniques for Fluid Status Assessment in Chronic Hemodialysis Patients.慢性血液透析患者液体状态评估技术的比较与可重复性
Cardiorenal Med. 2013 Jul;3(2):104-112. doi: 10.1159/000351008. Epub 2013 May 15.
5
Sympathetic activation and baroreflex function during intradialytic hypertensive episodes.透析中高血压发作期间的交感神经激活和压力感受反射功能。
PLoS One. 2012;7(5):e36943. doi: 10.1371/journal.pone.0036943. Epub 2012 May 22.
6
Serum vasopressin response in patients with intradialytic hypotension: a pilot study.血液透析中低血压患者的血清血管加压素反应:一项初步研究。
Clin J Am Soc Nephrol. 2008 May;3(3):729-35. doi: 10.2215/CJN.05341107. Epub 2008 Feb 6.
7
Revisiting the dialysate sodium prescription as a tool for better blood pressure and interdialytic weight gain management in hemodialysis patients.重新审视透析液钠处方,将其作为改善血液透析患者血压和透析间期体重增加管理的一种手段。
Clin J Am Soc Nephrol. 2008 Mar;3(2):522-30. doi: 10.2215/CJN.03360807. Epub 2008 Jan 16.
8
The effects of low calcium dialysate on arterial compliance and vasoactive substances in patients with hemodialysis.低钙透析液对血液透析患者动脉顺应性和血管活性物质的影响。
Korean J Intern Med. 2004 Mar;19(1):27-32. doi: 10.3904/kjim.2004.19.1.27.